We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$52.5B
AUM Growth
-$1.16B
(-2.2%)
Cap. Flow
-$399M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
2,386
New
193
Increased
800
Reduced
1,005
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$161M |
| 2 |
Invivyd
IVVD
|
+$94.7M |
| 3 |
Freeport-McMoran
FCX
|
+$88.6M |
| 4 |
Amgen
AMGN
|
+$87.7M |
| 5 |
Truist Financial
TFC
|
+$83.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$296M |
| 2 |
Pfizer
PFE
|
+$276M |
| 3 |
Cisco
CSCO
|
+$151M |
| 4 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
+$103M |
| 5 |
Evergy
EVRG
|
+$99.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.48% |
| 2 | Technology | 20.59% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Royal Bank of Canada
RY
$283B
| $12M | 0.02% |
120,896
+3,524
| +3% | +$359K |
|
602
Mettler-Toledo International
MTD
$26.7B
| $12M | 0.02% |
8,685
-660
| -7% | -$993K |
|
603
Eli Lilly
LLY
$1.01T
| $11.8M | 0.02% |
51,204
-16,417
| -24% | -$4.05M |
|
604
AbCellera Biologics
ABCL
$3.7B
| $11.8M | 0.02% |
590,000
+194,000
| +49% | +$3.43M |
|
605
Resideo Technologies
REZI
$2.84B
| $11.8M | 0.02% |
475,974
+235,851
| +98% | +$6.86M |
|
606
Edgewise Therapeutics
EWTX
$4.74B
| $11.6M | 0.02% |
700,000
| – | – |
|
607
Bloomin' Brands
BLMN
$686M
| $11.6M | 0.02% |
463,986
+146,173
| +46% | +$3.78M |
|
608
First Bancorp
FBNC
$2.65B
| $11.6M | 0.02% |
269,408
+12,768
| +5% | +$519K |
|
609
DoorDash
DASH
$85.9B
| $11.6M | 0.02% |
56,121
+55,331
| +7,004% | +$10.6M |
|
|
FUSN
610
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $11.5M | 0.02% |
1,453,890
+856,049
| +143% | +$7.21M |
|
611
Dell
DELL
$346B
| $11.4M | 0.02% |
216,860
+10,172
| +5% | +$507K |
|
612
Valero Energy
VLO
$114B
| $11.4M | 0.02% |
161,932
-50,870
| -24% | -$3.39M |
|
|
LVOX
613
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $11.4M | 0.02% |
+1,751,556
| New | +$12.6M |
|
614
SCYNEXIS
SCYX
$43.7M
| $11.3M | 0.02% |
266,194
| – | – |
|
615
Expedia Group
EXPE
$35.2B
| $11.2M | 0.02% |
68,522
+53,715
| +363% | +$8.3M |
|
|
PLYM
616
DELISTED
Plymouth Industrial REIT
PLYM
| $11.2M | 0.02% |
491,751
+37,837
| +8% | +$849K |
|
617
iShares MSCI India ETF
INDA
$6.45B
| $11.2M | 0.02% |
229,282
-10,912
| -5% | -$509K |
|
618
Sanofi
SNY
$102B
| $11.1M | 0.02% |
230,575
-9,792
| -4% | -$498K |
|
619
Acadia Pharmaceuticals
ACAD
$4.61B
| $11.1M | 0.02% |
+666,752
| New | +$12.9M |
|
620
Donnelley Financial Solutions
DFIN
$1.18B
| $11M | 0.02% |
317,827
+205,559
| +183% | +$6.79M |
|
621
Koppers
KOP
$866M
| $11M | 0.02% |
350,803
+19,706
| +6% | +$614K |
|
622
SPX Corp
SPXC
$8.93B
| $10.9M | 0.02% |
204,671
-91,613
| -31% | -$5.62M |
|
623
Fortis
FTS
$27.3B
| $10.9M | 0.02% |
245,149
+6,597
| +3% | +$299K |
|
624
EXL Service
EXLS
$5.5B
| $10.8M | 0.02% |
439,530
+27,870
| +7% | +$650K |
|
625
Axcelis
ACLS
$3.24B
| $10.8M | 0.02% |
229,170
+9,469
| +4% | +$412K |
|
Similar funds
Federated Hermes's Q3 2021 Portfolio in Review
As of Q3 2021, Federated Hermes held 2,386 positions worth $52.5B, down 2.2% from $53.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Federated Hermes's Q3 2021 filing shows 193 new, 800 increased, 1,005 reduced and 184 closed positions. Its largest new stake was GXO Logistics: 2,051,695 shares worth $161M. The largest sale was Moderna, an estimated $296M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2021 buy was GXO Logistics: 2,051,695 shares worth $161M.
- Federated Hermes added most to Freeport-McMoran in Q3 2021, an estimated $88.6M increase.
- Federated Hermes's biggest Q3 2021 reduction was Moderna, cutting an estimated $296M.
- Federated Hermes fully exited Translate Bio, Inc. Common Stock in Q3 2021, selling an estimated $103M.
- Federated Hermes's ten largest holdings make up 12% of its $52.5B portfolio in Q3 2021.
- Federated Hermes opened 193 new positions and closed 184 in Q3 2021.
- Federated Hermes's portfolio value fell 2.2% quarter-over-quarter to $52.5B.
Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.